Evidence map›Paper›PMID 39775013›Full record

Trial reportActa oncologica (Stockholm, Sweden)2025

Work ability following breast cancer - the MyHealth randomized controlled trial.

Trine A Horsbøl, Lena Saltbæk, Caroline Urhammer, Randi V Karlsen, Christoffer Johansen, Pernille E Bidstrup, Beverley L Høeg, Vibeke Zoffmann, Federica Belmonte, Ingelise Andersen and 6 more

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Acta oncologica (Stockholm, Sweden), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Effectiveness of eHealth interventions in long-term follow-up care for breast and gynecological cancer survivors: a systematic review.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Pooled it
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Trine A HorsbølNational Institute of Public Health, University of Southern Denmark, Copenhagen, Denmark; Cancer Survivorship, Danish Cancer Institute, Copenhagen, Denmark. tria@sdu.dk.ORCID 0000-0002-1278-9198
Lena SaltbækCancer Survivorship, Danish Cancer Institute, Copenhagen, Denmark; Department of Clinical Oncology and Palliative Care, Zealand University Hospital, Denmark.ORCID 0000-0002-2716-9469
Caroline UrhammerCancer Survivorship, Danish Cancer Institute, Copenhagen, Denmark.
Randi V KarlsenCancer Survivorship, Danish Cancer Institute, Copenhagen, Denmark.ORCID 0000-0002-7465-562X
Christoffer JohansenCancer Survivorship, Danish Cancer Institute, Copenhagen, Denmark; Institute of Clinical Medicine, Faculty of Health, Copenhagen University, Copenhagen, Denmark; Department of Oncology, CASTLE, Copenhagen University Hospital, Copenhagen, Denmark; Psychological Aspects of Cancer, Cancer Survivorship, Danish Cancer Institute, Copenhagen, Denmark.ORCID 0000-0002-4384-206X
Pernille E BidstrupPsychological Aspects of Cancer, Cancer Survivorship, Danish Cancer Institute, Copenhagen, Denmark; Institute of Psychology, Faculty of Social Sciences, Copenhagen University, Copenhagen, Denmark.ORCID 0000-0002-9704-6800
Beverley L HøegCancer Survivorship, Danish Cancer Institute, Copenhagen, Denmark.ORCID 0000-0002-9946-2429
Vibeke ZoffmannResearch Unit of Women's and Children's Health, the Juliane Marie Center, Copenhagen University Hospital, Copenhagen, Denmark.ORCID 0000-0003-0571-5331
Federica BelmonteStatistics and Data Analysis, Danish Cancer Institute, Copenhagen, Denmark.ORCID 0000-0002-2920-5005
Ingelise AndersenSection of Social Medicine, Department of Public Health, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark.ORCID 0000-0002-0076-265X
Anne S FribergCancer Survivorship, Danish Cancer Institute, Copenhagen, Denmark.ORCID 0000-0002-6421-4679
Mads N SvendsenDepartment of Clinical Oncology and Palliative Care, Zealand University Hospital, Denmark.ORCID 0000-0001-8082-359X
Helle G ChristensenDepartment of Clinical Oncology and Palliative Care, Zealand University Hospital, Denmark.
Vesna GlavicicDepartment of Clinical Oncology and Palliative Care, Zealand University Hospital, Denmark.
Dorte L NielsenInstitute of Clinical Medicine, Faculty of Health, Copenhagen University, Copenhagen, Denmark; Department of Oncology, Herlev and Gentofte University Hospital, Herlev, Denmark.ORCID 0000-0002-8766-8729
Susanne O DaltonCancer Survivorship, Danish Cancer Institute, Copenhagen, Denmark; Department of Clinical Oncology and Palliative Care, Zealand University Hospital, Denmark; Institute of Clinical Medicine, Faculty of Health, Copenhagen University, Copenhagen, Denmark.ORCID 0000-0002-5485-2730

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purposeWe previously demonstrated positive effects on quality of life and mental health following breast cancer when comparing a nurse-led follow-up program without scheduled visits (MyHealth) to regular follow-up. This study aims to examine whether MyHealth also positively impacts self-reported work ability. PATIENTS/MATERIAL AND

methodsA total of 288 patients, potentially active on the labour market, were randomized to MyHealth or control follow-up after primary treatment for early-stage breast cancer (2017-2019). MyHealth included individual self-management sessions, electronic symptom monitoring, and assistance with navigating healthcare services. Control follow-up consisted of biannual outpatient visits with a physician. Linear mixed-effect models were applied to evaluate the effect of MyHealth on self-reported work ability at 6, 12, 24, and 36 months after randomization as measured by the Work Ability Score (WAS).

resultsWork ability increased significantly in both groups during the first 6 months (mean WAS increase MyHealth: 1.64, 95% confidence interval [CI]: 1.26; 2.02 and control: 1.57, 95% CI: 1.17; 1.97) and continued to increase slightly but non-significantly (p-values > 0.13) until end of follow-up at 36 months. Improvement was especially pronounced among patients reporting poor work ability at baseline. Differences in mean WAS between patients in MyHealth and control follow-up were non-significant and close to zero at all time points (-0.21 to 0.48).

interpretationThe MyHealth follow-up program had no additional effect on self-reported work ability compared to regular follow-up. Future interventions should target patients with poor work ability and include components specifically designed to enhance work ability.

Indexed as

Breast NeoplasmsReturn to WorkAdultAgedFemaleFollow-Up StudiesHumansMiddle AgedQuality of LifeSelf-ManagementSelf ReportTelemedicineWork Capacity Evaluation

Identifiers

PMID39775013
PMCPMC11734303

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.